Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-4-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
901-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9081377-Aged,
pubmed-meshheading:9081377-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9081377-Female,
pubmed-meshheading:9081377-Head and Neck Neoplasms,
pubmed-meshheading:9081377-Humans,
pubmed-meshheading:9081377-Male,
pubmed-meshheading:9081377-Middle Aged,
pubmed-meshheading:9081377-Paclitaxel
|
pubmed:year |
1996
|
pubmed:articleTitle |
Single agent paclitaxel in advanced squamous cell head and neck carcinoma.
|
pubmed:publicationType |
Letter,
Clinical Trial,
Clinical Trial, Phase II
|